Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Distillerie Bonollo Umberto is a prominent Italian company specializing in the production of grappa and the extraction of high-value natural derivatives from viticulture by-products. While primarily known for its spirits, the company operates a sophisticated circular economy model that produces natural tartaric acid and grape-derived polyphenols for the pharmaceutical, nutraceutical, and cosmetic sectors. Their facilities utilize advanced distillation and extraction technologies to ensure high purity standards suitable for life science applications. The company is a key European supplier of bio-based ingredients, emphasizing sustainability through its integrated bioenergy and waste recovery systems. This unique industrial model allows the company to serve as a critical link between traditional agriculture and modern healthcare manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Distillerie Bonollo Umberto.